Skip to content

Assessment of the Photopill Capsule Treatment for safety and feasibility in healthy volunteers, a phase 1 trial

Assessment of the Photopill Capsule Treatment for safety and feasibility in healthy volunteers, a phase 1 trial - Photopill treatment, a phase 1 trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37258
Enrollment
4
Registered
2012-08-28
Start date
2012-08-30
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

darmen van gezonde proefpersonen, uiteindelijk doel is darmonstekingen te behandelen Inflammatory Bowel Disease Ulcerative Colitis

Interventions

After the rectum of the patient is cleaned with a Saline enema, the Photopill suppository capsule, mounted on a flexible rectal tube, will be inserted to the rectum till 10 cm. Finally the capsule w

Sponsors

Photopill Medical Ltd.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male or female subject between 18 and 65 years of age Subjects who are generally healthy Signed informed consent.

Exclusion criteria

Exclusion criteria: Subjects with any known GI related symptoms complaints or GI diseases Subjects with cancer or other life threatening diseases or conditions Subjects with cardiovascular or pulmonary diseases Pregnant women Subjects who underwent any colon surgery Morbid Obesity (BMI > 40) Drug abuse or alcoholism Bed-ridden Subject Participation in current clinical study or clinical study within 30 days prior to surgery

Design outcomes

Primary

MeasureTime frame
* Safety evaluation of the device as determined by the number and severity of Adverse Events in comparison to the baseline condition (Day 0 day 14, and unscheduled visits] * Comparison between baseline sigmoidoscopy assessments of mucosal appearance of the rectal mucosa, and the follow up assessments of the treated area (Day 0, Day 14).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)